MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021.
“We finished the year strong, highlighting the exceptional performance of our team and resiliency of our business model. For the full year, net revenue grew 15%, driving a 343-basis point improvement in EBITDA1 margin compared to the prior-year period,” commented Dr. Catherine Corrigan, President and Chief Executive Officer. “Our multi-disciplinary team of engineers and scientists continues to deliver unique and innovative solutions as we broaden our client base and deepen our relationships.”
“Among our proactive services, demand for human factors and machine learning studies was strong throughout 2021 and is expected to continue as clients seek curated, in-the-wild data to improve user experience and advance product performance. At the same time, within our reactive services, litigation related work continues to recover as courts further adapt operating procedures to the coronavirus environment,” continued Dr. Corrigan. “Over the last year we further evolved our capabilities, ensuring we can support our clients as they seek to deliver safer, healthier, and more sustainable products and services. Looking forward, we will remain diligent in our efforts to drive profitable growth, including expanding and developing our world-class talent as clients increasingly rely on Exponent’s disciplinary diversity and technical excellence.”
Fourth Quarter Financial Results
Total revenues and revenues before reimbursements for the fourth quarter of 2021 increased 9.9% to $113.5 million and 7.2% to $104.3 million as compared to $103.2 million and $97.3 million in the fourth quarter of 2020, respectively.
Net income decreased to $20.4 million, or $0.38 per diluted share, in the fourth quarter of 2021, as compared to $21.8 million, or $0.41 per diluted share, in the same period of 2020. The tax benefit for the classification of tax adjustments associated with share-based awards realized in the fourth quarter of 2021 was $0.1 million, as compared to $2.6 million or $0.05 per diluted share, in the fourth quarter of 2020. Inclusive of the tax benefit, Exponent’s consolidated tax rate was 28.9% in the fourth quarter, as compared to 18.6% for the same period in 2020.
EBITDA1 increased to $30.2 million, or 28.9% of net revenues, in the fourth quarter of 2021, as compared to $28.3 million, or 29.1% of net revenues in the fourth quarter of 2020.
Fiscal Year 2021 Financial Results
Total revenues and revenues before reimbursements for fiscal year 2021 increased 16.6% to $466.3 million and 14.9% to $434.9 million, respectively, as compared to $399.9 million and $378.4 million in fiscal year 2020.
Net income increased to $101.2 million, or $1.90 per diluted share, during fiscal year 2021, as compared to $82.6 million, or $1.55 per diluted share, in fiscal year 2020. The tax benefit for the classification of tax adjustments associated with share-based awards realized during fiscal year 2021 was $10.0 million or $0.19 per diluted share, as compared to $12.3 million or $0.23 per diluted share during fiscal year 2020. Inclusive of the tax benefit, Exponent’s consolidated tax rate was 19.6% in fiscal year 2021, as compared to 14.8% in fiscal year 2020.
EBITDA1 increased to $132.3 million, or 30.4% of net revenues, during fiscal year 2021, as compared to $102.1 million, or 27.0% of net revenues, in fiscal year 2020.
During fiscal year 2021, Exponent paid $43.2 million in dividends, repurchased $7.0 million of common stock, and closed the period with $297.7 million in cash, cash equivalents and short-term investments.
In a separate press release today, Exponent announced an increase in its quarterly cash dividend from $0.20 to $0.24 to be distributed on March 25, 2022, and reiterated its intent to continue to pay quarterly dividends.
Business Overview
Exponent’s engineering and other scientific segment represented 81% of the Company’s net revenues in the fourth quarter of 2021 and 82% for the fiscal year 2021. Net revenues in this segment increased 8% in the fourth quarter and 17% during fiscal year 2021 as compared to the prior year period. Growth during the quarter and full year remained broad-based, with continued strong demand for Exponent's services across the utilities, consumer electronics, consumer products, life sciences and automotive sectors.
Exponent’s environmental and health segment represented 19% of the Company’s net revenues in the fourth quarter and 18% during fiscal year 2021. Net revenues in this segment increased 5% for the fourth quarter and full year 2021, compared to the same period in the prior year. Growth in this segment, which saw less impact from business restrictions in 2020, was primarily driven by Exponent’s proactive safety-related work evaluating the impacts of chemicals on human health and the environment.
Business Outlook
“As our suite of offerings and key markets expands, so does the demand for our multidisciplinary services. At the onset of the coronavirus pandemic, we acted swiftly in the face of uncertainty to align our business to protect profitability, but as demand for our services increased, we accelerated our recruiting efforts. While the job market for engineering and scientific talent remains highly competitive, we persist in our ability to attract world-class talent, which will begin to bear fruit in 2022 and beyond,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer.
For the first quarter of 2022 as compared to the same period one year prior, Exponent anticipates:
- Revenues before reimbursements to grow in the mid- to high-single digits; and,
- EBITDA1 margin to decrease 50 to 125 basis points.
For the full year 2022 as compared to the same period one year prior, Exponent anticipates:
- Revenues before reimbursements to grow in the mid- to high-single digits; and,
- EBITDA1 margin to decrease 200 to 250 basis points.
“For over 50 years, Exponent has harnessed the power of technical excellence, objectivity, and disciplinary diversity to help unravel the complexities of innovations as they become reality. Through new and emerging opportunities in automation, electric vehicles, digital health and more, we remain well-positioned to advise our clients as society continues raising the bar on safety, health, sustainability, reliability and performance. Our fourth quarter and fiscal 2021 results exemplify Exponent’s sustainable business model and financial strength, ultimately driving strong profitability and long-term value for our shareholders,” concluded Dr. Corrigan.
Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, Thursday, February 3, 2022, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (323) 701-0225 or (888) 394-8218. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (719) 457-0820 or (888) 203-1112 and entering passcode 1882592#.
Footnotes
1 EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.
About Exponent
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's interdisciplinary organization of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 50 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges of sustainability.
Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.
Forward Looking Statements
This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the COVID-19 pandemic (including factors relating to measures implemented by governmental authorities or by us to promote the safety of our employees, vendors and clients; other direct and indirect impacts on our business and the businesses of our clients, vendors and other partners; impacts which may, among other things, adversely affect our clients’ ability to utilize our services at the levels they have previously; disruptions of access to our facilities or those of our clients or third parties; and increased and potentially significant economic uncertainty and volatility, including credit and collectability risks and potential disruptions of capital and credit markets), the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
Source: Exponent, Inc.
| EXPONENT, INC. | |||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||
| For the Quarters Ended December 31, 2021 and January 1, 2021 | |||||||||||
| (unaudited) | |||||||||||
| (in thousands, except per share data) | |||||||||||
| Quarters Ended | Years Ended | ||||||||||
| December 31, | January 1, | December 31, | January 1, | ||||||||
| 2021 | 2021 | 2021 | 2021 | ||||||||
| Revenues | |||||||||||
| Revenues before reimbursements | $ | 104,336 | $ | 97,330 | $ | 434,850 | $ | 378,412 | |||
| Reimbursements | 9,170 | 5,909 | 31,419 | 21,488 | |||||||
| Revenues | 113,506 | 103,239 | 466,269 | 399,900 | |||||||
| Operating expenses | |||||||||||
| Compensation and related expenses | 67,556 | 69,500 | 278,047 | 250,041 | |||||||
| Other operating expenses | 8,746 | 8,498 | 32,594 | 32,234 | |||||||
| Reimbursable expenses | 9,170 | 5,909 | 31,419 | 21,488 | |||||||
| General and administrative expenses | 4,656 | 1,598 | 15,282 | 12,888 | |||||||
| Total operating expenses | 90,128 | 85,505 | 357,342 | 316,651 | |||||||
| Operating income | 23,378 | 17,734 | 108,927 | 83,249 | |||||||
| Other income (expense), net | |||||||||||
| Interest income, net | 12 | 209 | 66 | 1,705 | |||||||
| Miscellaneous income, net | 5,265 | 8,886 | 16,844 | 11,982 | |||||||
| Total other income (expense), net | 5,277 | 9,095 | 16,910 | 13,687 | |||||||
| Income before income taxes | 28,655 | 26,829 | 125,837 | 96,936 | |||||||
| Income taxes | 8,275 | 4,989 | 24,635 | 14,384 | |||||||
| Net income | $ | 20,380 | $ | 21,840 | $ | 101,202 | $ | 82,552 | |||
| Net income per share: | |||||||||||
| Basic | $ | 0.39 | $ | 0.42 | $ | 1.92 | $ | 1.58 | |||
| Diluted | $ | 0.38 | $ | 0.41 | $ | 1.90 | $ | 1.55 | |||
| Shares used in per share computations: | |||||||||||
| Basic | 52,647 | 52,402 | 52,610 | 52,388 | |||||||
| Diluted | 53,359 | 53,260 | 53,331 | 53,323 | |||||||
| EXPONENT, INC. | |||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
| December 31, 2021 and January 1, 2021 | |||||||
| (unaudited) | |||||||
| (in thousands) | |||||||
| December 31, | January 1, | ||||||
| 2021 | 2021 | ||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 297,687 | $ | 197,525 | |||
| Short-term investments | - | 45,001 | |||||
| Accounts receivable, net | 139,861 | 111,565 | |||||
| Prepaid expenses and other assets | 15,214 | 12,741 | |||||
| Total current assets | 452,762 | 366,832 | |||||
| Property, equipment and leasehold improvements, net | 59,971 | 59,823 | |||||
| Operating lease right-of-use asset | 14,370 | 19,322 | |||||
| Goodwill | 8,607 | 8,607 | |||||
| Other assets | 148,029 | 125,512 | |||||
| Total Assets | $ | 683,739 | $ | 580,096 | |||
| Liabilities and Stockholders' Equity | |||||||
| Current liabilities: | |||||||
| Accounts payable and accrued liabilities | $ | 24,504 | $ | 16,327 | |||
| Accrued payroll and employee benefits | 103,552 | 83,194 | |||||
| Deferred revenues | 19,762 | 11,800 | |||||
| Operating lease liability | 5,164 | 5,987 | |||||
| Total current liabilities | 152,982 | 117,308 | |||||
| Other liabilities | 103,885 | 86,947 | |||||
| Operating lease liability | 9,807 | 14,343 | |||||
| Total liabilities | 266,674 | 218,598 | |||||
| Stockholders' equity: | |||||||
| Common stock | 66 | 66 | |||||
| Additional paid-in capital | 281,419 | 265,328 | |||||
| Accumulated other comprehensive loss | (1,983 | ) | (1,932 | ) | |||
| Retained earnings | 478,370 | 421,809 | |||||
| Treasury stock, at cost | (340,807 | ) | (323,773 | ) | |||
| Total stockholders' equity | 417,065 | 361,498 | |||||
| $ | 683,739 | $ | 580,096 | ||||
| EXPONENT, INC. | |||||||||||||||||||||||
| EBITDA and EBITDAS (1) | |||||||||||||||||||||||
| For the Quarters Ended December 31, 2021 and January 1, 2021 | |||||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Quarter Ended | Years Ended | ||||||||||||||||||||||
| December 31, | January 1, | December 31, | January 1, | ||||||||||||||||||||
| 2021 | 2021 | 2021 | 2021 | ||||||||||||||||||||
| Net Income | $ | 20,380 | $ | 21,840 | $ | 101,202 | $ | 82,552 | |||||||||||||||
| Add back (subtract): | |||||||||||||||||||||||
| Income taxes | 8,275 | 4,989 | 24,635 | 14,384 | |||||||||||||||||||
| Interest income, net | (12 | ) | (209 | ) | (66 | ) | (1,705 | ) | |||||||||||||||
| Depreciation and amortization | 1,544 | 1,695 | 6,487 | 6,871 | |||||||||||||||||||
| EBITDA (1) | 30,187 | 28,315 | 132,258 | 102,102 | |||||||||||||||||||
| Stock-based compensation | 4,024 | 3,952 | 19,263 | 17,278 | |||||||||||||||||||
| EBITDAS (1) | $ | 34,211 | $ | 32,267 | $ | 151,521 | $ | 119,380 | |||||||||||||||
| (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. | |||||||||||||||||||||||
